A detailed history of Sym Financial Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Sym Financial Corp holds 3,010 shares of ABT stock, worth $348,949. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,010
Previous 2,742 9.77%
Holding current value
$348,949
Previous $284,000 20.77%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $26,818 - $31,658
268 Added 9.77%
3,010 $343,000
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $276,201 - $308,310
2,742 New
2,742 $284,000
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $181,732 - $222,456
2,015 New
2,015 $221,000
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $367,398 - $416,209
-5,604 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $340,779 - $411,109
5,604 New
5,604 $411,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sym Financial Corp Portfolio

Follow Sym Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sym Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sym Financial Corp with notifications on news.